Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 3284 entries
View as:

A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)

Phase: N/A Priority: Normal
NCT ID: NCT02127710 Org: User:
Start: 04/30/14 End: 04/20/20 Due: 04/20/21

Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00612027 Org: User:
Start: 01/31/06 End: - Due: -

A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05818514 Org: User:
Start: 04/27/23 End: 07/11/23 Due: 07/11/24

Safety and Efficacy of Exenatide as Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00381342 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00960661 Org: User:
Start: 09/30/09 End: 08/31/12 Due: 08/31/13

Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05526690 Org: User:
Start: 10/28/20 End: 12/12/20 Due: 12/12/21

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

Phase: N/A Priority: Normal
NCT ID: NCT00242307 Org: User:
Start: 05/31/04 End: 06/30/07 Due: 06/30/08

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02937818 Org: User:
Start: 11/28/16 End: 11/27/23 Due: 11/27/24

National Survey on Hypertension in General Practitioner (GP) Consultation

Phase: N/A Priority: Normal
NCT ID: NCT00695656 Org: User:
Start: 04/30/08 End: 11/30/08 Due: 11/30/09

A Phase I, Open-Label, Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03276052 Org: User:
Start: 10/14/21 End: 11/26/21 Due: 11/26/22

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01498185 Org: User:
Start: 02/29/12 End: 10/31/12 Due: 10/31/13

Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01012375 Org: User:
Start: 11/30/09 End: 08/31/10 Due: 08/31/11

One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

Phase: N/A Priority: Normal
NCT ID: NCT00758589 Org: User:
Start: 09/30/08 End: 07/31/09 Due: 07/31/10

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05294458 Org: User:
Start: 03/28/22 End: 09/12/22 Due: 09/12/23

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

Phase: N/A Priority: Normal
NCT ID: NCT00891462 Org: User:
Start: 04/30/09 End: 11/30/09 Due: 11/30/10

Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.

Phase: N/A Priority: Normal
NCT ID: NCT02355145 Org: User:
Start: 04/02/15 End: 07/28/16 Due: 07/28/17

Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01387308 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

Phase: N/A Priority: Normal
NCT ID: NCT00525824 Org: User:
Start: 08/31/07 End: 09/30/08 Due: 09/30/09

Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage

Phase: N/A Priority: Normal
NCT ID: NCT00524329 Org: User:
Start: 01/31/06 End: 10/31/07 Due: 10/31/08

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

Phase: N/A Priority: Normal
NCT ID: NCT05817110 Org: User:
Start: 04/20/23 End: 12/01/26 Due: 12/01/27

ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)

Phase: N/A Priority: Normal
NCT ID: NCT00090363 Org: User:
Start: 07/31/04 End: 08/31/11 Due: 08/31/12

MEOI and HRQoL in CLL Patients Treated With BTKis

Phase: N/A Priority: Normal
NCT ID: NCT04938141 Org: User:
Start: 10/07/21 End: 09/26/24 Due: 09/26/25

Observational Study on the Treatment of Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06676436 Org: User:
Start: 11/30/24 End: 11/30/25 Due: 11/30/26

A Single and Multiple Dose Study to Assess Blood and Urine Drug Levels of Fostamatinib in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01608542 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone

Phase: N/A Priority: Normal
NCT ID: NCT01257412 Org: User:
Start: 01/31/12 End: 06/30/13 Due: 06/30/14